ICYMI: PhRMA CMO Dr. Michael Ybarra speaks with Dr. Fabian Sandoval about clinical trial diversity
Enhancing clinical trial diversity is a challenge, but with a multi-faceted, community-centered approach, we can help underrepresented patients be more involved in the research and development of potential life-saving medical treatments.
Source: The Catalyst - Category: Pharmaceuticals Authors: Michael Ybarra Tags: Clinical Trials Equity Source Type: news
More News: Clinical Trials | Pharmaceuticals